ALFA Finder| Revenue growth | 26% YoY Consolidated |
|---|---|
| Margins | Insurance Combined Ratio improved 30 bps to 102.7% |
| Demand visibility | Strong retail health insurance growth of 45% |
Growth
Revenue grew 26% YoY. Care Health GWP rose 37% to Rs. 3,247 Cr. Broking PAT grew 65% to Rs. 7.5 Cr.
Outlook
Planned Rs. 250 Cr capital infusion for RHDFCL; scaling up MSME lending in RFL; digital-first transformation across all business verticals.
Risks
Consolidated PAT loss of Rs. 46.9 Cr; RBI communication regarding demerger requires further clarifications; Housing finance GNPA at 4.4%.
Last quarter's promises, checked
Delivered
- Guided Care GWP growth > industry → delivered 37% vs 20% industry (= BEAT)
- Guided RFL to be debt-free → delivered RFL balance sheet entirely debt-free (= BEAT)
- Guided Care combined ratio improvement → delivered 101.4% vs 102.6% prev (= BEAT)
Partly delivered
- Guided demerger scheme implementation → delivered RBI request for further clarifications (= PARTIAL)
Missed
- Guided Care PBT INR 539 Cr (FY26) → delivered Q1 FY27 consolidated loss INR 46.9 Cr (= MISS)
Investor Presentation filed with BSE, NSE: RELIGARE. Summary written with AI assistance from the document.
Religare Enterprises Ltd: key numbers
- Share price
- ₹233.93
- Market cap
- ₹8,065 Cr
- Revenue (annual)
- ₹8,459 Cr
- Net profit (annual)
- ₹85.96 Cr
- P/E (TTM)
- -238.1×Sector 21.0×
- Promoter holding
- 31.26%+0.70% QoQ
- FII holding
- 9.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Religare Enterprises Ltd
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Religare Enterprises Earnings Call Transcript: Key Takeaways
Consolidated H1 loss of ₹145 Cr persists; profit rests on Care Health's Ind AS PBT (₹392 Cr, +42%) while NBFC and broking remain small and in build-out.
Religare Enterprises Investor Presentation: Key Takeaways
Religare H1 FY27 consolidated total income Rs4,717 Cr (+19% YoY); PAT loss Rs145 Cr vs Rs54 Cr profit last year. Care GWP growth drives insurance; Finvest lending restarted 6 Nov 2026.
Religare Enterprises Q2 FY27 Results: Net Loss of ₹97.7 Cr
Religare Enterprises Ltd reported revenue from operations of ₹2,381 Cr (+14.6% YoY) and a net loss of ₹97.7 Cr for Q2 FY27.
- Key figure
- Net loss ₹97.7 Cr
Religare Enterprises Employee Stock Options
Religare Enterprises' NRC granted 25,998 stock options under its ESOP 2019 scheme. Options vest in 5 equal annual tranches at Rs. 230.78 per share exercise price.
Religare Enterprises Business Update
Religare Finvest, a material subsidiary, resumed lending after RBI lifted its Corrective Action Plan. It disbursed its first Loan Against Property on 6 November 2026.